抑制p53通过下调miR-215-5p、-199-5p/-3p抗UUO小鼠肾纤维化的机制研究

基本信息
批准号:81570646
项目类别:面上项目
资助金额:82.00
负责人:张东山
学科分类:
依托单位:中南大学
批准年份:2015
结题年份:2019
起止时间:2016-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:成梅初,金丽艳,李益坚,张磊,刘佳,杨儒好,许玄,杨俊芹
关键词:
微小RNA199a5p微小RNA199a3p微小RNA2155pp53肾纤维化
结项摘要

P53 is one of the important cancer gene suppression, we showed p53 regulates multiple gene classes to protect against acute kidney injury, the newly study indicated that p53 involved in the fibrosis regulation, but the role of fibrosis was exactly opposite in different organs and models. Therefore, this project intends to use the classic renal fibrosis model of unilateral ureteral obstruction (UUO), and investigate the role and molecular mechanism of p53 on TIF. Recent studies showed that miRNA also involved in the regulation of renal fibrosis. Pre-experiment demonstrated that inhibition p53 with pif-a significantly ameliorated renal fibrosis in UUO model, and significantly down-regulated expression of miR-215-5p, -199a-5p and -199a-3p using microRNAs chip, which was further confirmed by Real time PCR and Northern blot ways. Therefore, this project will explore the role and molecular mechanism of p53 on expression of miR-215-5p, -199a-5p and -199a-3p. Furthermore, the predicted direct target genes and related signal pathway,CTNNBIP1, Caveolin1 and SOCS7, were respectively regulated by miR-215-5p, -199a-5p and -199a-3p, which need to be demonstrated. To establish UUO mice model with p53 knockout, and kidney samples from CKD (IgA nephropathy, diabetic nephropathy and renal biopsy in patients with hypertensive nephropathy) patients will reveal p53 anti-fibrosis role and above molecular mechanism. This study will elucidate the molecular mechanism of p53 anti-fibrosis and provide scientific theoretical and a new target for the prevention of renal fibrosis from cells, animal, people in three levels.

p53是重要的抑癌基因之一,新近发现p53参与调控纤维化,但对肾纤维化的作用及机制仍不完全清楚。因此,本项目拟采用梗阻性肾病(UUO)模型,探讨p53调控肾纤维化的作用及机制。预实验显示通过pif-a抑制p53显著减轻UUO模型肾纤维化,microRNAs芯片表达谱、Real time PCR和Northern blot证明pif-a干预UUO组显著下调miR-215-5p、-199a-5p和-199a-3p的表达。为此,本项目拟通过抑制p53探讨TGF-β上调上述miRs的分子机制,证明上述miRs调控相应的预测靶基因CTNNBIP1、Caveolin1和SOCS7的表达,深入阐明上述靶基因调控纤维化的信号机制,并使用p53敲除小鼠UUO模型和CKD(IgA肾病、糖尿病肾病和高血压肾病)患者肾活检的标本揭示其抗纤维化的作用及机制,为抑制p53抗纤维化提供科学的理论依据和新的防治靶点。

项目摘要

p53是重要的抑癌基因之一,新近发现p53参与调控纤维化,但对肾纤维化的作用及机制仍不完全清楚。因此,本项目拟采用梗阻性肾病(UUO)模型,探讨p53调控肾纤维化的作用及机制。预实验显示通过pif-a抑制p53显著减轻UUO模型肾纤维化,microRNAs芯片表达谱、Real time PCR和Northern blot证明pif-a干预UUO组显著下调miR-215-5p、-199a-5p和-199a-3p的表达。为此,本项目拟通过抑制p53探讨TGF-β上调上述miRs的分子机制,证明上述miRs调控相应的预测靶基因CTNNBIP1、Caveolin1和SOCS7的表达,深入阐明上述靶基因调控纤维化的信号机制,并使用p53敲除小鼠UUO模型和CKD(IgA肾病、糖尿病肾病和高血压肾病)患者肾活检的标本揭示其抗纤维化的作用及机制,为抑制p53抗纤维化提供科学的理论依据和新的防治靶点。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
2

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

DOI:10.13692/ j.cnki.gywsy z yb.2016.03.002
发表时间:2016
3

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
4

精子相关抗原 6 基因以非 P53 依赖方式促进 TRAIL 诱导的骨髓增生异常综合征 细胞凋亡

精子相关抗原 6 基因以非 P53 依赖方式促进 TRAIL 诱导的骨髓增生异常综合征 细胞凋亡

DOI:
发表时间:2018
5

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

DOI:
发表时间:2017

张东山的其他基金

批准号:81870475
批准年份:2018
资助金额:57.00
项目类别:面上项目
批准号:81100507
批准年份:2011
资助金额:23.00
项目类别:青年科学基金项目

相似国自然基金

1

Taxol抗UUO模型肾间质纤维化的机制研究

批准号:81100507
批准年份:2011
负责人:张东山
学科分类:H0503
资助金额:23.00
项目类别:青年科学基金项目
2

PILRα通过下调β2整合素活化抑制肾脏纤维化的调节作用和分子机制研究

批准号:81700587
批准年份:2017
负责人:杜邱娜
学科分类:H0502
资助金额:20.00
项目类别:青年科学基金项目
3

去甲斑蝥素通过抑制PP2A介导β-catenin去磷酸化修饰的抗肾间质纤维化分子机制研究

批准号:81370792
批准年份:2013
负责人:李瑛
学科分类:H0502
资助金额:70.00
项目类别:面上项目
4

HGF下调ILK表达抑制血管内皮细胞EndMT抗心肌纤维化作用的机制研究

批准号:81370265
批准年份:2013
负责人:陆方林
学科分类:H0202
资助金额:70.00
项目类别:面上项目